Home

Recro Pharma, Inc.

CIK 1588972 · last filed 2019-11-22

Recro Pharma, Inc. is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2019. The most recent filing, for BXRXV, was dated Nov 22, 2019. The firm reports its address in Exton, PA. 62 SEC filings were submitted jointly with Ryan David Lake.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

1

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
1 E. UWCHLAN AVE, SUITE 112
EXTON, PA 19341
Phone
(770) 534-8239
State of Incorporation
PA
Formerly Known As
Recro Pharma, Inc. (2013–2022)
Related Filers
Ryan David Lake — 62 joint filings, latest 2024-04-08
GERALDINE HENWOOD — 31 joint filings, latest 2021-05-17
Broadfin Capital, LLC — 24 joint filings, latest 2020-02-13
J DAVID ENLOE JR — 23 joint filings, latest 2024-04-08
Wayne Weisman — 22 joint filings, latest 2024-04-08
WINSTON J CHURCHILL — 21 joint filings, latest 2024-04-08
SCP Vitalife Partners II LP — 21 joint filings, latest 2020-12-28
William Ashton — 17 joint filings, latest 2024-04-08
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Baudax Bio, Inc. (BXRXV) Delisted 10%+ Owner 0 — — $0 1 2019-11-22

Recent Filings

1 filing
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-11-22 Baudax Bio, Inc. (BXRXV) Delisted Other (J) −100 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.